Literature DB >> 9747764

Estimating influenza-related hospitalization in The Netherlands.

R M Baltussen1, A Reinders, M J Sprenger, M J Postma, J C Jager, A J Ament, R M Leidl.   

Abstract

The purpose of this study was to examine the impact of influenza on hospitalization in The Netherlands. Two methods were applied to estimate this effect: (a) regression analysis and (b) comparison of hospitalization in epidemic years with non-epidemic years. Hospital discharge rates in 1984-93 have been considered. The study shows that, during the period studied, on average, almost 2700 people were hospitalized for influenza per annum, and that influenza was diagnosed as the main cause for hospitalization in only a fraction of these hospitalizations (326: 12%). From an economic perspective, these results imply that the cost-effectiveness of vaccination against influenza may be severely underestimated when looking only at changes achieved in the number of hospitalizations attributed to influenza.

Entities:  

Mesh:

Year:  1998        PMID: 9747764      PMCID: PMC2809483          DOI: 10.1017/s0950268898008966

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

Review 1.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

2.  The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.

Authors:  Verena H Menec; Charlyn Black; Leonard MacWilliam; Fred Y Aoki
Journal:  Can J Public Health       Date:  2003 Jan-Feb

3.  Three-year (1999-2002) of epidemiological and virological surveillance of influenza in north-east Italy.

Authors:  F Ansaldi; P D'Agaro; P Burgnich; D de Florentiis; S Favero; G Dal Molin; M Comar; N Coppola; C Campello
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 4.  Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Authors:  M J Postma; J M Bos; M van Gennep; J C Jager; R Baltussen; M J Sprenger
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 5.  Influenza vaccination in the elderly: impact on hospitalisation and mortality.

Authors:  Kristin L Nichol
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Influenza-attributable deaths, Canada 1990-1999.

Authors:  D L Schanzer; T W S Tam; J M Langley; B T Winchester
Journal:  Epidemiol Infect       Date:  2007-02-19       Impact factor: 2.451

Review 7.  Economic evaluation is essential in healthcare for the elderly. A viewpoint.

Authors:  R Leidl; D Stratmann
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

8.  Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.

Authors:  Maarten J Postma; Annoesjka Novak; Huib W K F H Scheijbeler; Marlene Gyldmark; Marianne L L van Genugten; Jan C Wilschut
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

9.  Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004.

Authors:  Baltazar Nunes; Cecile Viboud; Ausenda Machado; Corinne Ringholz; Helena Rebelo-de-Andrade; Paulo Nogueira; Mark Miller
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

10.  Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Authors:  Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.